University of Guelph-affiliated company to provide WeedMD with innovative tissue cultured-plant services via Steadystem Solutions for cloning accuracy and plant asset preservation

WeedMD announced today its financial results for the three months ended March 31, 2020.

Company’s products on ‘Medical Cannabis by Shoppers’ platform, registered under blockchain-enabled program added to University Health Network’s research trials

Amendments to the terms of the Company’s $39 million senior secured credit facility provide WeedMD with greater financial flexibility

Sequential 325% quarter-over-quarter growth signals strong demand and brand recognition

Strain-specific ‘Aurum’ vapes produced in-house at Company’s CX Industries’ facility expands Company’s medical product portfolio

Pilot project ‘PatientDirect’ kicks off in June with express delivery to Toronto-area patients

Kicks-off second-year outdoors with over 18,000 plants slated for fall harvest, confirms 2019 outdoor biomass now in extraction for new cannabis formats at CX Industries

WeedMD announced today its financial results for the fiscal year ended December 31, 2019, including a 162% net revenue increase to $20.8 million, compared with $8.0 million for the prior year.

WeedMD announced today that it will file its financial statements for the first quarter ended March 31, 2020 on or before July 15, 2020.

The Company will host a conference call on Thursday, June 11, 2020, at 10 a.m. ET.

WeedMD is pleased to announce that Angelo Tsebelis, Chief Executive Officer and Stephen Ng, Chief Commercial Officer, will be presenting in Canaccord Genuity’s 4th Annual Global Cannabis Virtual Conference.

Company provides corporate update including COVID-19 impact and confirms earnings conference call will be held on Thursday, May 28, 2020 at 10 a.m. Eastern Time

Primes 27-acres in Strathroy, ON for early June 2020 planting and fall harvest

WeedMD issued the following public statement in response to the United Food and Commercial Workers Union (“UFCW Canada”) public notification.

Lincoln Greenidge brings over 20 years of corporate finance, M&A, capital markets and operations experience to the WeedMD team

Starseed is now the preferred medical cannabis supplier to the Insulators Local 95 Health & Welfare Trust Fund through their benefits program

Starseed is now the preferred medical cannabis supplier to IUPAT Province of Ontario Health & Welfare Trust Fund through their benefits program

New licence allows for ongoing product development and the evaluation of cannabis concentrates in portable vaporizer devices for optimal formulations

Starseed and WeedMD become preferred medical cannabis suppliers to over 51,000 myHSA clients across Canada